These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A novel small molecule inhibitor of influenza A viruses that targets polymerase function and indirectly induces interferon. Ortigoza MB; Dibben O; Maamary J; Martinez-Gil L; Leyva-Grado VH; Abreu P; Ayllon J; Palese P; Shaw ML PLoS Pathog; 2012; 8(4):e1002668. PubMed ID: 22577360 [TBL] [Abstract][Full Text] [Related]
23. Cappariloside A shows antiviral and better anti-inflammatory effects against influenza virus via regulating host IFN signaling, in vitro and vivo. Li Z; Zhao J; Zhou H; Li L; Ding Y; Li J; Zhou B; Jiang H; Zhong N; Hu W; Yang Z Life Sci; 2018 May; 200():115-125. PubMed ID: 29555588 [TBL] [Abstract][Full Text] [Related]
24. A GFP expressing influenza A virus to report in vivo tropism and protection by a matrix protein 2 ectodomain-specific monoclonal antibody. De Baets S; Verhelst J; Van den Hoecke S; Smet A; Schotsaert M; Job ER; Roose K; Schepens B; Fiers W; Saelens X PLoS One; 2015; 10(3):e0121491. PubMed ID: 25816132 [TBL] [Abstract][Full Text] [Related]
25. Protective effect of fluvastatin on influenza virus infection. Peng J; Zhang D; Ma Y; Wang G; Guo Z; Lu J Mol Med Rep; 2014 Jun; 9(6):2221-6. PubMed ID: 24676773 [TBL] [Abstract][Full Text] [Related]
26. Direct Inhibition of Cellular Fatty Acid Synthase Impairs Replication of Respiratory Syncytial Virus and Other Respiratory Viruses. Ohol YM; Wang Z; Kemble G; Duke G PLoS One; 2015; 10(12):e0144648. PubMed ID: 26659560 [TBL] [Abstract][Full Text] [Related]
27. Cryptoporus volvatus extract inhibits influenza virus replication in vitro and in vivo. Gao L; Sun Y; Si J; Liu J; Sun G; Sun X; Cao L PLoS One; 2014; 9(12):e113604. PubMed ID: 25437846 [TBL] [Abstract][Full Text] [Related]
28. Antiviral activity of formyl peptide receptor 2 antagonists against influenza viruses. Courtin N; Fotso AF; Fautrad P; Mas F; Alessi MC; Riteau B Antiviral Res; 2017 Jul; 143():252-261. PubMed ID: 28483551 [TBL] [Abstract][Full Text] [Related]
29. Saikosaponin A inhibits influenza A virus replication and lung immunopathology. Chen J; Duan M; Zhao Y; Ling F; Xiao K; Li Q; Li B; Lu C; Qi W; Zeng Z; Liao M; Liu Y; Chen W Oncotarget; 2015 Dec; 6(40):42541-56. PubMed ID: 26637810 [TBL] [Abstract][Full Text] [Related]
30. Isoliquiritigenin inhibits virus replication and virus-mediated inflammation via NRF2 signaling. Wang H; Jia X; Zhang M; Cheng C; Liang X; Wang X; Xie F; Wang J; Yu Y; He Y; Dong Q; Wang Y; Xu A Phytomedicine; 2023 Jun; 114():154786. PubMed ID: 37002973 [TBL] [Abstract][Full Text] [Related]
31. Cell type- and replication stage-specific influenza virus responses in vivo. Fay EJ; Aron SL; Macchietto MG; Markman MW; Esser-Nobis K; Gale M; Shen S; Langlois RA PLoS Pathog; 2020 Aug; 16(8):e1008760. PubMed ID: 32790753 [TBL] [Abstract][Full Text] [Related]
32. Anti-influenza activity of berberine improves prognosis by reducing viral replication in mice. Yan YQ; Fu YJ; Wu S; Qin HQ; Zhen X; Song BM; Weng YS; Wang PC; Chen XY; Jiang ZY Phytother Res; 2018 Dec; 32(12):2560-2567. PubMed ID: 30306659 [TBL] [Abstract][Full Text] [Related]
33. Novel effect of methionine enkephalin against influenza A virus infection through inhibiting TLR7-MyD88-TRAF6-NF-κB p65 signaling pathway. Tian J; Jiao X; Wang X; Geng J; Wang R; Liu N; Gao X; Griffin N; Shan F Int Immunopharmacol; 2018 Feb; 55():38-48. PubMed ID: 29220721 [TBL] [Abstract][Full Text] [Related]
34. Identification of a novel compound targeting the nuclear export of influenza A virus nucleoprotein. Huang F; Chen J; Zhang J; Tan L; Lu G; Luo Y; Pan T; Liang J; Li Q; Luo B; Zhang H; Lu G J Cell Mol Med; 2018 Mar; 22(3):1826-1839. PubMed ID: 29193684 [TBL] [Abstract][Full Text] [Related]
36. GFP-expressing influenza A virus for evaluation of the efficacy of antiviral agents. Kim JI; Park S; Lee I; Lee S; Shin S; Won Y; Hwang MW; Bae JY; Heo J; Hyun HE; Jun H; Lim SS; Park MS J Microbiol; 2012 Apr; 50(2):359-62. PubMed ID: 22538668 [TBL] [Abstract][Full Text] [Related]
37. Antivirally active ribavirin analogues--4,5-disubstituted 1,2,3-triazole nucleosides: biological evaluation against certain respiratory viruses and computational modelling. Krajczyk A; Kulinska K; Kulinski T; Hurst BL; Day CW; Smee DF; Ostrowski T; Januszczyk P; Zeidler J Antivir Chem Chemother; 2014 Jan; 23(4):161-71. PubMed ID: 23538746 [TBL] [Abstract][Full Text] [Related]
38. Germacrone inhibits early stages of influenza virus infection. Liao Q; Qian Z; Liu R; An L; Chen X Antiviral Res; 2013 Dec; 100(3):578-88. PubMed ID: 24095670 [TBL] [Abstract][Full Text] [Related]
39. Toxoplasma gondii GRA7-Induced TRAF6 Activation Contributes to Host Protective Immunity. Yang CS; Yuk JM; Lee YH; Jo EK Infect Immun; 2016 Jan; 84(1):339-50. PubMed ID: 26553469 [TBL] [Abstract][Full Text] [Related]
40. [In vitro and in vivo effects of a long-acting anti-influenza agent CS-8958 (laninamivir octanoate, Inavir) against pandemic (H1N1) 2009 influenza viruses]. Kubo S; Kakuta M; Yamashita M Jpn J Antibiot; 2010 Oct; 63(5):337-46. PubMed ID: 21268406 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]